Peregrine Pharmaceuticals

Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now
Wall Street Cheat Street
Sat, 09/29/12 - 12:08 pm
Insmed
Dendreon
Peregrine Pharmaceuticals
Vivus
Arena Pharmaceuticals
Pomerantz Law Firm Has Filed a Class Action Against Peregrine Pharmaceuticals, Inc. -- PPHM
Yahoo/GlobeNewsWire
Sat, 09/29/12 - 11:53 am
Peregrine Pharmaceuticals
lawsuits
An 80% Plunge Leads the Biotech Bloodbath
Motley Fool
Tue, 09/25/12 - 12:41 pm
Peregrine Pharmaceuticals
Vertex Pharmaceuticals
Questcor
Arena Pharmaceuticals
Vivus
Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup
TheStreet.com
Mon, 09/24/12 - 11:08 am
Peregrine Pharmaceuticals
lung cancer
bavituximab
3 Companies With Exciting Phase II Trial Data Close Out 2012
Seeking Alpha
Mon, 09/10/12 - 11:02 am
Peregrine Pharmaceuticals
bavituximab
Vigabatrin
Catalyst Pharmaceutical Partners
OncoSec
NeoPulse
Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT
Wall Street Cheat Street
Sat, 09/8/12 - 10:51 am
Peregrine Pharmaceuticals
Opexa
bavituximab
non-small cell lung cancer
Neptune Technologies & Bioresources
This New Cancer Drug is Boosting Peregrine Pharmaceuticals 48%!
Wall Street Cheat Street
Sat, 09/8/12 - 10:40 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tue, 09/4/12 - 12:27 pm
Gilead
Salix
Peregrine Pharmaceuticals
Navidea Biopharmaceuticals
Crofelemer
tobramycin
Lymphoseek
bavituximab
Truvada
Eylea
Regeneron
lixivaptan
Cornerstone Therapeutics
Peregrine: Bavi Results Are Overhyped And Inconclusive
Seeking Alpha
Wed, 08/22/12 - 11:12 am
bavituximab
Peregrine Pharmaceuticals
cancer
Peregrine provides additional Bavituxima preclinical prostate cancer data
Yahoo/Fly on the Wall
Wed, 04/4/12 - 09:39 am
Peregrine Pharmaceuticals
bavituximab
prostate cancer
Peregrine Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Sat, 03/10/12 - 04:01 pm
Peregrine Pharmaceuticals
earnings
Peregrine's cancer drug data disappoints; shares plunge
Reuters
Fri, 03/9/12 - 04:21 pm
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
Peregrine Provides Update on HCV Clinical Program
Yahoo
Thu, 12/29/11 - 10:30 pm
HCV
Peregrine Pharmaceuticals
bavituximab
Peregrine's Lung Cancer Drug Has Promising Trial
Seeking Alpha
Wed, 12/7/11 - 04:53 pm
lung cancer
Peregrine Pharmaceuticals
bavituximab
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Seeking Alpha
Tue, 11/22/11 - 11:57 am
Lpath
lipid signaling
Peregrine Pharmaceuticals
Novartis
Pfizer
Biogen Idec
SIRO Clinpharm and Peregrine Pharmaceuticals highlight successful collaboration
PharmaLive
Sat, 10/15/11 - 01:10 pm
Peregrine Pharmaceuticals
SIRO Clinpharm
monoclonal antibodies
glioblastoma multiforme
Cotara
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Seeking Alpha
Mon, 10/3/11 - 12:37 pm
Achillion
Aeterna Zentaris
Antigenics
Ariad
Amylin
Amarin
BioDelivery Sciences
Cyclacel
Geron
Dendreon
PharmAthene
Zalicus
Human Genome Sciences
Keryx
Peregrine Pharmaceuticals
SIGA technologies
YM BioSciences
Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial
Yahoo
Wed, 08/24/11 - 09:23 am
Peregrine Pharmaceuticals
breast cancer
monoclonal antibodies
bavituximab
lung cancer
Peregrine Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Fri, 07/15/11 - 01:08 am
earnings
Peregrine Pharmaceuticals
Peregrine Pharma's Secret Weapon
Minyanville
Wed, 06/29/11 - 10:46 pm
Peregrine Pharmaceuticals

Pages